TrialRMD open2020

Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.

Philip S Helliwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.